Digital Mammography Market

The Digital Mammography Market is valued at USD 2.1 Bn in 2026 and is projected to reach USD 4.3 Bn, growing at a CAGR of 11% by 2033.

Rising Prevalence of Breast Cancer to Fuel Growth of Digital Mammography Market

Highly safe, non-invasive, and effective screening technology for breast cancer. By delivering better results, digital mammography eliminates the need for re-tests and follow-up screenings. The rising prevalence of breast cancer and the growing need among patients for early-stage diagnosis are some of the key factors expected to increase demand for breast cancer diagnostic devices over the projected period, hence propelling the worldwide digital mammography market forward. In 2022, women in the United States are predicted to be diagnosed with 287,850 new instances of invasive breast cancer and 51,400 new cases of non-invasive breast cancer. Over the course of her lifetime, one in every eight American women (about 13%) will get aggressive breast cancer. The need for digital mammography systems is expected to rise because of this hence driving the growth of the market.

Increased access to breast cancer screening systems, as well as expanding government initiatives to promote clinical interpretation, are likely to drive market expansion. In April 2022, the Punjab government struck an agreement with Roche Pharma India and Niramai Health to establish the PINK Project, a breast cancer treatment effort. Furthermore, the collaboration might include data sharing, R&D, and upgrading RadNet's fleet of Hologic mammography devices to cutting-edge imaging technology, which will accelerate the expansion of the digital mammography market. In September 2020, Candelis Inc. and GE Healthcare announced a collaboration to improve mammography workflow, image management, and storage capabilities for the Senographe Pristina Mammography System. As a result, the reasons, combined with changing consumer demands, are likely to fuel market expansion. ​

AI will play an important role in digital mammography and digital breast tomosynthesis (DBT), from image creation and denoising to risk prediction, cancer diagnosis, and therapy selection, as well as outcome prediction. Such improvements are projected to provide profitable potential for market players. In June 2020, Vara, a Berlin-based firm, raised EUR 6.5 million in Series A funding for AI-powered breast cancer screening software.

Cost-Effectiveness of 2D Full-Field Digital Mammography Tomosynthesis Drives Growth of Digital Mammography Market

The 2D full-field digital mammography tomosynthesis segment is expected to dominate the market over the forecast period. The price difference between 2D and 3D mammography is the fundamental reason behind this. Furthermore, this technology is cost-effective because it lowers recall rates, and insurance and reimbursements for these devices are generally available in industrialised countries. When compared to screen film technology, the exposure period to radiation in 2D mammography equipment is reduced, resulting in higher-quality images and better positioning. It also provides experts with better results and clearer photographs. It is the most widely used screening method and is widely accepted as a gold standard for breast cancer diagnosis in practically all developed healthcare markets.

Increased Adoption of Technologically Advanced Mammography Units in North America to Drive Growth of Digital Mammography Market

North America is expected to dominate the global digital mammography market, owing to the adoption of technologically advanced mammography units by diagnostic imaging centres and hospitals, and expanding reimbursement coverage by governments and other health care facilities in the region. The key drivers of the market in this region are the rising prevalence of breast cancer, considerable R&D in breast cancer medicines, and breakthroughs in breast imaging modalities. According to Breastcancer.org, there are 276,480 new instances of invasive breast cancer diagnosed in women in 2020. End-users in this region are replacing traditional systems with the most contemporary technologies due to the rising breast cancer burden and rising healthcare expenses.

The investment of several organisations in breast cancer screening activities is also boosting the market growth. The Society of Breast Imaging in the United States is dedicated to reducing the burden of breast cancer and preserving patients' lives. It has a Research & Education Fund project that aims to help with breast imaging research and education through grants. Similarly, the Promise Fund of Florida intends to expand its reach by 2022, helping more than 30,000 women in South Florida through a Continuum of Care strategy that aids women in South Florida from breast and cervical cancer screening to treatment. It combines a Women's Health Facility with a federally designated health centre to provide mammography services. Investments flowing in will thus remain instrumental to the build-up of digital mammography market in the region.

Asia Pacific is expected to grow at a significant rate over the forecast period. The rise can be due to the rising prevalence of breast cancer and increased awareness of the benefits of mammography technology. According to a study published in the LWW magazine, Asia accounts for roughly 44 % of global breast cancer deaths, with Asia also accounting for 39 % of BC cases identified. Furthermore, breast cancer accounts for approximately a quarter of all female cancer cases in India. However, the industry is being driven by government initiatives for free cancer screening programmes. In October 2021, the Goa government launched "Swasth Mahila, Swasth Goa", a free breast cancer screening programme for 1 lakh women. Greater Chennai Corporation announced steps to enhance breast cancer awareness in November 2021. It screened roughly 1.17 lakh, women, for breast cancer at its community and urban primary health centres between 2020 and 2021. As a result, demand for mammography systems in the region continues to rise, thereby fuelling the growth of digital mammography market.

In May 2022, at the SBI/ACR Breast Imaging Symposium 2022, Volpara Health unveiled new products for their integrated platform for delivering individualised breast care. Mammography quality and reporting, volumetric breast density measurements, and cancer risk assessment are all provided by Volpara's AI-driven breast software solutions. On the other hand, in January 2022, with the debut of Transpara, an AI Breast Care system, ScreenPoint Medical increased its footprint in the United States and in 30 nations across the world.

A few of the players in the digital mammography market include:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Hologic, Inc.
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Carestream Health
• Konica Minolta, Inc.
• Samsung Medison
• Shimadzu Corporation
• Planmed Oy
• Agfa-Gevaert Group
• Hitachi Medical Systems
• Esaote SpA
• Toshiba

Global Digital Mammography Market is Segmented as Below:

By Technology
• 2D Full Field Digital Mammography
• 3D Full Field Digital Mammography (Digital Breast Tomosynthesis)
• Contrast Enhanced Digital Mammography

By Product Type
• Digital Mammography System
• Display Unit
• Central Processing Units
• Visualization Software

By End User
• Hospitals and Surgical Centers
• Breast Care Centers
• Diagnostics Centers

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa